Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 707

2.

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.

Morris MJ, Akhurst T, Osman I, Nunez R, Macapinlac H, Siedlecki K, Verbel D, Schwartz L, Larson SM, Scher HI.

Urology. 2002 Jun;59(6):913-8.

PMID:
12031380
3.

123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.

Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL.

J Nucl Med. 2009 Aug;50(8):1237-43. doi: 10.2967/jnumed.108.060467. Epub 2009 Jul 17.

4.

Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.

Kushner BH, Yeh SD, Kramer K, Larson SM, Cheung NK.

J Clin Oncol. 2003 Mar 15;21(6):1082-6.

PMID:
12637474
5.

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.

Taggart DR, Han MM, Quach A, Groshen S, Ye W, Villablanca JG, Jackson HA, Mari Aparici C, Carlson D, Maris J, Hawkins R, Matthay KK.

J Clin Oncol. 2009 Nov 10;27(32):5343-9. doi: 10.1200/JCO.2008.20.5732. Epub 2009 Oct 5.

6.

Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.

Nuñez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM.

J Nucl Med. 2002 Jan;43(1):46-55.

7.

¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Melzer HI, Coppenrath E, Schmid I, Albert MH, von Schweinitz D, Tudball C, Bartenstein P, Pfluger T.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1648-58. doi: 10.1007/s00259-011-1843-8. Epub 2011 May 27.

PMID:
21617976
9.

Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.

Franzius C, Hermann K, Weckesser M, Kopka K, Juergens KU, Vormoor J, Schober O.

J Nucl Med. 2006 Oct;47(10):1635-42.

10.

Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.

Nakamoto Y, Osman M, Wahl RL.

Clin Nucl Med. 2003 Apr;28(4):302-7.

PMID:
12642709
11.

Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.

Claudiani F, Stimamiglio P, Bertolazzi L, Cabria M, Conte M, Villavecchia GP, Garaventa A, Lanino E, De Bernardi B, Scopinaro G.

Q J Nucl Med. 1995 Dec;39(4 Suppl 1):21-4.

PMID:
9002744
12.

The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.

Andrich MP, Shalaby-Rana E, Movassaghi N, Majd M.

Pediatrics. 1996 Feb;97(2):246-50.

PMID:
8584386
13.

Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.

Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D.

Mol Imaging Biol. 2003 Jan-Feb;5(1):26-31.

PMID:
14499159
14.

Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.

Yanagawa T, Watanabe H, Inoue T, Ahmed AR, Tomiyoshi K, Shinozaki T, Oriuchi N, Endo K, Takagishi K.

J Comput Assist Tomogr. 2003 Mar-Apr;27(2):175-82.

PMID:
12703009
15.

Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.

Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.

Cancer. 2002 Feb 15;94(4):879-88.

16.

Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma.

Kim PJ, Hicks RJ, Wirth A, Ryan G, Seymour JF, Prince HM, Mac Manus MP.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):740-6. doi: 10.1016/j.ijrobp.2008.08.037. Epub 2008 Nov 27.

PMID:
19038505
17.

[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.

Purz S, Mauz-Körholz C, Körholz D, Hasenclever D, Krausse A, Sorge I, Ruschke K, Stiefel M, Amthauer H, Schober O, Kranert WT, Weber WA, Haberkorn U, Hundsdörfer P, Ehlert K, Becker M, Rössler J, Kulozik AE, Sabri O, Kluge R.

J Clin Oncol. 2011 Sep 10;29(26):3523-8. doi: 10.1200/JCO.2010.32.4996. Epub 2011 Aug 8.

18.

Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET.

Menzel C, Graichen S, Berner U, Risse JH, Diehl M, Döbert N, Hamscho N, Grünwald F.

Acta Med Austriaca. 2003;30(2):37-40.

PMID:
12752086
19.
20.

Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).

Kut V, Spies W, Spies S, Gooding W, Argiris A.

Am J Clin Oncol. 2007 Feb;30(1):45-50.

PMID:
17278894
Items per page

Supplemental Content

Write to the Help Desk